English
Testingfunctionalities
ElsevierHealthcareHub
ElsevierHealthcareHub
Title
NCBIfeed
Subtitle
- Efficacy and safety of anti-COVID-19 vaccination in patients with autoimmune blistering diseases: A French national study.
- Kidney involvement in children during the SARS-CoV-2 Omicron variant pandemic.
- Survival benefit of a third dose of the COVID-19 vaccine among hemodialysis patients: A prospective cohort study.
- Year 2022: exploring COVID-19 pandemic in children.
- Potential long-term neurological and gastrointestinal effects of COVID-19: A review of adult cohorts.
- Long-term dynamic shifts in genomic base content and evolutionary trajectories of SARS-CoV-2 variants.
- Comparative effectiveness of mRNA-1273 and BNT162b2 COVID-19 vaccines in immunocompromised individuals: a systematic review and meta-analysis using the GRADE framework.
- Novel B-Cell Epitopes of Non-Neutralizing Antibodies in the Receptor-Binding Domain of the SARS-CoV-2 S-Protein with Different Effects on the Severity of COVID-19.
- The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL.
- Systemic immune profiling of Omicron-infected subjects inoculated with different doses of inactivated virus vaccine.
- Occupational differences in the prevalence and severity of long-COVID: analysis of the Coronavirus (COVID-19) Infection Survey.
- The relationship between vaccine acceptance and COVID-19 mortality in Europe: A Cross-Country analysis of public opinion and Epidemiological data.
- Correction to: Phenotypic evolution of SARS-CoV-2: a statistical inference approach.
- Ancestral, Delta, and Omicron (BA.1) SARS-CoV-2 strains are dependent on serine proteases for entry throughout the human respiratory tract.
- SARS-CoV-2 papain-like protease (PLpro) inhibitory and antiviral activity of small molecule derivatives for drug leads.
- Kinetics and durability of nucleocapsid-specific antibodies after SARS-CoV-2 reinfection.
- Sequential heterologous immunization with COVID-19 vaccines induces broader neutralizing responses against SARS-CoV-2 variants in comparison with homologous boosters.
- Author Correction: Virtual reality for assessing stereopsis performance and eye characteristics in Post-COVID.
- CCL2 Promotes Novel Coronavirus-Mediated Inflammatory Responses in Macrophages.
- COVID-19 and cardiovascular disease in patients with chronic kidney disease.
- Examining bias from differential depletion of susceptibles in vaccine effectiveness estimates in settings of waning.
- Is there an association between peri-diagnostic vaccination and clinical outcomes in COVID-19 patients?
- How has the strict lockdown during the SARS-COV-2 outbreak changed the diet of Spaniards?
- Impact of the Severe acute respiratory syndrome coronavirus 2 pandemic on mortality associated with healthcare-associated infections.
- Predicting post-COVID-19 cognitive deficits.
- Effects of spike proteins on angiotensin converting enzyme 2 (ACE2).
- Autoimmune encephalitis in COVID-19 patients: a systematic review of case reports and case series.
- Approaches to evaluate the specific immune responses to SARS-CoV-2.
- Prevalence and risk factors of psychological symptoms and quality of life in COVID-19 survivors: A cross-sectional study of three different populations.
- The use of cardiac markers in the prediction of COVID-19.
Practice Update RSS
PracticeUpdateRSS
- Vitamin D Deficiency and Development of Complications in Individuals With Type 1 and Type 2 Diabetes
- Unannounced Meal Challenges Using an Advanced Hybrid Closed-Loop System
- Pharmacist-Led Intervention Lowers HbA1c in Type 2 Diabetes
- Racial, Ethnic Differences Seen for Benefits of Antihyperglycemic Agents
- CDC: 22 States Have an Adult Obesity Prevalence ≥35 Percent
- FDA Adds Warning to Ozempic Label About Risk for Blocked Intestines
- Relationship Between Obesity and In-Hospital Outcomes in Individuals With Type 2 Diabetes and STEMI
- Effects of Canagliflozin on the Outcomes of Patients With Type 2 Diabetes in Subgroups of Population-Specific BMI
- 37 Percent Diagnosed With Type 1 Diabetes After Age 30
- Many Receiving Alpelisib for Metastatic Breast Cancer Have Hyperglycemia
